"covid-19" research and development for the completion of clinical studies and trials in outbreak settings to prepare for evaluation of medical countermeasures (mcms. Clins 0003 and 0004 specific to…
Active Other Transaction Agreement Awarded Last action
- Contract number
- W911QY2090004
- Awardee
-
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. UEI UYLKBRENAPG5
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $72,506,117
Award facts
- Contract value 78% obligated
-
- $88,329,353.02 Current, with exercised options
- $92,445,087.00 Potential, with all options
- Completion date 87% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Competition
- Not Competed Only One Source
- Pricing
- Other
- Place of performance
- Westlake, MD 20817, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $1,794,420 | |
| Funding Only Action | -$116,836 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $500,000 | |
| Supplemental Agreement for work within scope | $55,905 | |
| Funding Only Action | $750,000 | |
| Funding Only Action | $500,000 | |
| Supplemental Agreement for work within scope | $250,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $649,999 | |
| Supplemental Agreement for work within scope | -$627,112 | |
| Supplemental Agreement for work within scope | $8,423,120 | |
| Supplemental Agreement for work within scope | $21,300,000 | |
| Funding Only Action | $2,370,916 | |
| Funding Only Action | -$2,000,000 | |
| Supplemental Agreement for work within scope | $2,000,000 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $5,261,129 | |
| Supplemental Agreement for work within scope | $8,000,000 | |
| Funding Only Action | -$380,389 | |
| Funding Only Action | $16,500,000 | |
| Funding Only Action | $1,700,000 | |
| Original award | $5,574,965 |
Show all 24
About this award
The Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense awarded an Other Transaction Agreement to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. with a ceiling value of $92.445 million on March 27, 2020, for COVID-19 research and development including clinical studies and trials in outbreak settings to evaluate medical countermeasures, with ultimate completion September 30, 2027. This OTA sits outside the FAR and operates under alternative transaction authority.
The effort encompasses two clinical line items (CLINs 0003 and 0004) focused specifically on COVID-19, alongside broader trials and studies supporting development of medical countermeasures to combat biological threats in CONUS and OCONUS environments. Work is performed at Westlake, Maryland. The foundation supports the JPEO mission to develop and deploy efficient clinical trial platforms enabling evaluation of investigational medical countermeasures and advanced technologies during outbreak conditions, leveraging its established Outbreak Clinical Trials program infrastructure and FDA-regulated clinical trial expertise.
Major research initiatives under this OTA include multi-site adaptive platform trials for early treatment and post-exposure prophylaxis evaluation, observational studies of COVID-19 outpatients and physiologic responses, outbreak-ready clinical research capacity development in resource-limited settings, and wearable biosensor integration for physiological monitoring and prognostic marker identification. Notable subcontractors and collaborators include Duke University and Johns Hopkins University (clinical trial design and site coordination), Enlisense LLC (cartridge-based C-reactive protein diagnostic optimization), Makerere University Walter Reed Program and The Infectious Diseases Institute (outbreak research in Uganda), Afrims Thai Component (infectious disease surveillance in Thailand), University of Malaya (clinical research in Malaysia and Cambodia), Transperfect Global (French and Malagasy document translation), and research support providers including Information Management Services, Inc., Berry Consultants LLC, and FHI Clinical Inc.
Description
"covid-19" research and development for the completion of clinical studies and trials in outbreak settings to prepare for evaluation of medical countermeasures (mcms. Clins 0003 and 0004 specific to covid-19.
Subawards
Show all 28
Quick answers
Who was awarded contract W911QY2090004?
W911QY2090004 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on March 27, 2020.
How much is contract W911QY2090004 worth?
The government has obligated $72,506,117 on W911QY2090004. Its current value, with exercised options, is $88,329,353. Its potential value, with all options, is $92,445,087.
Which agency awarded contract W911QY2090004?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2090004, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY2090004 competed?
The extent of competition for W911QY2090004 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award